Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 21,987 results that match your search.21,987 results
  • In a decision rendered by OHIM's opposition division on April 23 2014, in opposition case no B 002183450 – Automobili Laborghini SPA v Societatea de Investitii Financiare Moldova SA – the examiners found that no likelihood of confusion exists between trade marks having similar figurative elements and dissimilar verbal elements, irrespective of the degree of similarity between the services designated by the two signs.
  • Getting and presenting evidence to establish your trade secret claims in China can be difficult. Christine Yiu discusses strategies on how to gather and present your evidence
  • Section 3 of the Industrial Designs Act 1996 defines an industrial design as excluding "features of shape or configuration of an article which are dictated solely by the function which the article has to perform".
  • The UK will this month host a summit on IP enforcement. James Nurton visited UK IP Minister Lord Younger to ask him what it is and what he expects it to achieve
  • From time to time people want to trade on the popularity of certain names. In this case, Businessinvestgroup, a Russian company, filed a word trade mark application (number 2012722575) for ПРОХОРОВСКОЕ ПОЛЕ (Prokhorovka Battlefield) in respect of alcoholic beverages, class 33. The Patent Office refused the registration.
  • Sherry Knowles of Knowles Intellectual Property Strategies responds to the USPTO’s explanation of its controversial Myriad guidelines in a guest article
  • A crowded marketplace and increased regulatory pressure are among the headaches for GSK’s trade mark team, reports Simon Crompton
  • Carl Battle has a big job on his hands managing pharmaceutical giant GlaxoSmithKline’s patent team. Michael Loney talks to him and some of his staff about bringing Anoro Ellipta to market, the dreaded patent cliff, combating generic drug companies and navigating developing countries’ IP hostility
  • On April 28 2014, the US Trade Representative (USTR) posted on its website that the Philippines has been removed from the Special 301 Watch List. The USTR publishes its annual Special 301 Report, which identifies countries with inadequate and ineffective laws or measures for the protection of IP rights which serve as trade barriers to US companies and products. The Philippines has been on this list since 1989.
  • The Portuguese IP Code dated 1940 computed the term of a patent by counting 15 years from the grant date. Later, the IP Code of 1995 introduced the term of a patent as 20 years from the filing date. However, for those patents filed before 1995 and granted after, the term calculation was made by considering the greater protection that could be given. Since the grant process could take, in some cases, seven or eight years, the duration of a patent could be more than 20 years from the application date! Further, when SPC applications based on those patents were filed, the total protection could be 27 or 28 years or even more.